Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Araújo
Evaldo Stanislau Affonso de
ES
Campos
Aleia Faustina
AF
Yamashiro
Juliana
J
Mello
Evandro Sobrosa
ES
Takagaki
Teresa
T
Barone
Antonio Alci
AA
D000998:Antiviral Agents / Q000009:adverse effects*; D001982:Bronchial Diseases / Q000139:chemically induced*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a